Articles by Natalie Grover

Natalie Grover

Latest from this author

FDA Seeks More Data On Sarepta Muscle Disorder Drug, Shares Slump

Sarepta Therapeutics Inc said the U.S. Food and Drug Administration had asked for additional data on its lead drug, delaying its marketing application by about six months.
    MOST Read
    1. RAW FARM Cheese, E. Coli, and the Food Recall the FDA Requested but Did Not Get
    2. What Do Celebrities Actually Eat at the Oscars? The 2026 After-Party Menu Revealed
    3. Foods That Lower Blood Pressure: 10 Picks Nutritionists Actually Recommend
    4. Starbucks Harry Potter Collaboration 2026: The Limited Edition Drinks Asia Has Been Waiting For
    5. Homemade Ramen That Rivals the Restaurant Bowl: A Japanese Ramen Recipe Guide
    News